QQQ $ 422.58 $ -3.07 (-0.72 %)
DIA $ 378.81 $ 0.76 (0.2 %)
SPY $ 500.35 $ -1.63 (-0.32 %)
TLT $ 88.50 $ 0.65 (0.74 %)
GLD $ 213.80 $ 1.92 (0.91 %)
$ 0.05265
-- x --
-- x --
-- - --
$ 0.05 - $ 0.20
129,930
na
0
$ 1.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 psyched-suggestibility-and-psychedelics-effects-eus-7m-research-fund-australias-treatment-delivery-bz-podcast-and-more

New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedel...

 numinus-wellness-continues-tight-expense-management-with-strategic-reviews-underway

Psychedelics mental healthcare company Numinus Wellness (OTCQX: NUMIF) posted its financial results for the three months ended ...

 30-psychedelics-executives-scientists--influencers-to-watch-in-2024-and-beyond

The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic pot...

 psyched-defense-depts-ketamine-trial-cybins-psilocybin-metabolic-disorders-reform-update-and-more

Defense Dept. Funds Ketamine Study For PTSD Treatment 

 numinus-reports-q4--full-year-fiscal-2023-results-including-greatly-reduced-cash-burn-rate

Psychedelic therapy clinic provider Numinus Wellness (TSX:NUMI) (OTC: NUMIF) announced 

 psychedelics-researchers--industry-leaders-weigh-in-on-groundbreaking-ptsd-treatment-news

The long-awaited psychedelic-assisted treatment alternative for Post-Traumatic Stress Disorder (PTSD) is moving closer to feder...

 psychedelic-drugs-market-will-generate-over-12b-in-next-12-years-ny-consulting-firm-predicts

NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections ...

 psyched-75m-in-federal-funds-gov-polis-opens-maps-event-cnns-show-dock-ellis-lsd-pitch--more

Federal Psychedelics: $75M Grant Program

 mdma-deals-optimi-supplies-numinus-maps-program--pharmala-exports-to-australian-university

Numinus Wellness (OTCMKTS: NUMIF) with support from the Multidisciplinary Association for Psychedelic Studies (MAPS) will utili...

 psyched-75m-in-federal-funds-gov-polis-opens-maps-event-cnns-show-dock-ellis-lsd-pitch--more

Federal Psychedelics: $75M Grant Program

 numinus-partners-with-maps-to-conduct-phase-1-mdma-assisted-therapy-investigational-study

In a prelude to what is hoped will be regulatory approval of MDMA-assisted therapy in the U.S. and Canada, Numinus Wellness Inc...

 numinus-clinical-arm-to-lead-enrollment-site-for-mindmeds-phase-2b-lsd-study

Mental healthcare company Numinus Wellness (OTCQX: NUMIF) announced its contract research organization Cedar Clinical Research ...

 psyched-lsd-microdosing-for-depression-dmt-for-anxiety-mdma-octopuses-and-more

Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study Australian psychedelics company...

 numinus-clinical-site-joins-compass-phase-3-program-on-psilocybin-therapy-for-trd

Numinus Wellness Inc.’s (OTCMKTS: NUMIF) wholly-owned contract research organization Cedar Clinical Research has commenced a ne...

 psyched-lsd-for-major-depression-canadas-psilocybin-macrodose-trial-treatments-for-multiple-sclerosis-and-more

LSD Trial Study Shows Potential For Major Depression Psychedelics biopharma company Mind Medicine Inc. (NASDAQ: MNMD) recent...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION